An MLP classifier for prediction of HBV-induced liver cirrhosis using routinely available clinical parameters

Disease Markers

Volumn 35, Issue 6, 2013, Pages 653-660

  Cao, Yuan ^a   Hu, Zhi De ^a   Liu, Xiao Fei ^a   Deng, An Mei ^b   Hu, Cheng Jin ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHILD PUGH SCORE; CLASSIFIER; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTHROMBIN TIME; RED CELL DISTRIBUTION WIDTH; THROMBOCYTE COUNT;

HEPATITIS B VIRUS;

ADULT; ALANINE TRANSAMINASE; ALGORITHMS; ALKALINE PHOSPHATASE; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; BAYES THEOREM; BIOLOGICAL MARKERS; ERYTHROCYTE INDICES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PLATELET COUNT; PROTHROMBIN TIME; ROC CURVE; SOFTWARE;

EID: 84888862141     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/127962     Document Type: Article

References (46)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
2. Forner A., Llovet J. M., Bruix J., Hepatocellular carcinoma. The Lancet 2012 379 9822 1245 1255 2-s2.0-84859212951 10.1016/S0140-6736(11)61347-0
3. Berzigotti A., Ashkenazi E., Reverter E., Abraldes J. G., Bosch J., Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension. Disease Markers 2011 31 3 129 138 2-s2.0-81155123615 10.3233/DMA-2011-0835
4. Lavanchy D., Hepatitis B virus epidemiology, disease burden, treatment, arid current and emerging prevention and control measures. Journal of Viral Hepatitis 2004 11 2 97 107 2-s2.0-1642410856 10.1046/j.1365-2893.2003.00487.x
5. Ringelhan M., Heikenwalder M., Protzer U., Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development. Digestive Diseases 2013 31 1 138 151 10.1159/000347209
6. Erdogan S., Dogan H. O., Sezer S., Uysal S., Ozhamam E., Kayacetin S., Koca: Y., The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients. Scandinavian Journal of Clinical & Laboratory Investigation 2013 10.3109/00365513.2013.773592
7. Poon T. C. W., Hui A. Y., Chan H. L. Y., Ang I. L., Chow S. M., Wong N., Sung J. J. Y., Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clinical Chemistry 2005 51 2 328 335 2-s2.0-12944295220 10.1373/clinchem.2004.041764
8. Pinzani M., Rombouts K., Colagrande S., Fibrosis in chronic liver diseases: diagnosis and management. Journal of Hepatology 2005 42 supplement 1 S22 S36 2-s2.0-14944343292 10.1016/j.jhep.2004.12.008
9. Abenavoli L., Corpechot C., Poupon R., Elastography in hepatology. Canadian Journal of Gastroenterology 2007 21 12 839 842 2-s2.0-39149122802
10. Fraquelli M., Rigamonti C., Casazza G., Conte D., Donato M. F., Ronchi G., Colombo M., Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007 56 7 968 973 2-s2.0-34247631059 10.1136/gut.2006.111302
11. Fraquelli M., Branchi F., The role of transient elastography in patients with hepatitis B viral disease. Digestive and Liver Disease 2011 43 supplement 1 S25 S31 2-s2.0-78650634916 10.1016/S1590-8658(10)60689-5
12. Leroy V., Hilleret M.-N., Sturm N., Trocme C., Renversez J.-C., Faure P., Morel F., Zarski J.-P., Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. Journal of Hepatology 2007 46 5 775 782 2-s2.0-34047173013 10.1016/j.jhep.2006.12.013
13. Sebastiani G., Serum biomarkers for the non-invasive diagnosis of liver fibrosis: the importance of being validated. Clinical Chemistry and Laboratory Medicine 2012 50 4 595 597 2-s2.0-84860430120 10.1515/cclm-2011-0850
14. The guidelines of prevention and treatment for chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2005 13 881 891
15. Pugh R. N. H., Murray Lyon I. M., Dawson J. L., Pietroni M. C., Williams R., Transection of the oesophagus for bleeding oesophageal varices. The British Journal of Surgery 1973 60 8 646 649 2-s2.0-0015854966
16. Mark Hall E. F., Holmes G., Pfahringer B., Reutemann P., Ian H., The WEKA data mining software: an update. ACM SIGKDD Explorations Newsletter 2009 11 1 10 18
17. Cao Y., He K., Cheng M., Si H. Y., Zhang H. L., Song W., Li A. L., Hu C. J., Wang: N., Two classifiers based on serum peptide pattern for prediction of HBV-induced liver cirrhosis using MALDI-TOF MS. BioMed Research International 2013 2013 7 814876 10.1155/2013/814876
18. Wai C.-T., Greenson J. K., Fontana R. J., Kalbfleisch J. D., Marrero J. A., Conjeevaram H. S., Lok A. S.-F., A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 38 2 518 526 2-s2.0-0042265556 10.1053/jhep.2003.50346
19. Sterling R. K., Lissen E., Clumeck N., Sola R., Correa M. C., Montaner J., Sulkowski M. S., Torriani F. J., Dieterich D. T., Thomas D. L., Messinger D., Nelson M., Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006 43 6 1317 1325 2-s2.0-33745547388 10.1002/hep.21178
20. Vergara I. A., Norambuena T., Ferrada E., Slater A. W., Melo F., StAR: a simple tool for the statistical comparison of ROC curves. BMC Bioinformatics 2008 9, article 265 2-s2.0-46049119818 10.1186/1471-2105-9-265
21. Pinzani M., Rosselli M., Zuckermann M., Liver cirrhosis. Best Practice and Research 2011 25 2 281 290 2-s2.0-79954471274 10.1016/j.bpg.2011.02.009
22. Schuppan D., Afdhal N. H., Liver cirrhosis. The Lancet 2008 371 9615 838 851 2-s2.0-40049097359 10.1016/S0140-6736(08)60383-9
23. Castera L., Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012 142 6 1293.e4 1302.e4 2-s2.0-84860299294 10.1053/j.gastro.2012.02.017
24. Jin W., Lin Z., Xin Y., Jiang X., Dong Q., Xuan S., Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterology 2012 12, article 14 2-s2.0-84857017520 10.1186/1471-230X-12-14
25. Viana M. S. V. B., Takei K., Yamaguti D. C. C., Guz B., Strauss E., Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. Annals of Hepatology 2009 8 1 26 31 2-s2.0-62549128711
26. Guzelbulut F., Sezikli M., Akkan-Cetinkaya Z., Yasar B., Ozkara S., Kurdas-Ovunc A. O., AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B. Turkish Journal of Gastroenterology 2012 23 4 353 358
27. Seto W.-K., Lee C.-F., Lai C.-L., Ip P. P. C., Fong D. Y.-T., Fung J., Wong D. K.-H., Yuen M.-F., A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B. PLoS One 2011 6 8 2-s2.0-80051604371 10.1371/journal.pone.0023077 e23077
28. Yilmaz Y., Yonal O., Kurt R., Bayrak M., Aktas B., Ozdogan O., Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): usefulness in patients with chronic liver disease. Hepatitis Monthly 2011 11 2 103 106 2-s2.0-79952479754
29. Lin C.-S., Chang C.-S., Yang S.-S., Yeh H.-Z., Lin C.-W., Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Internal Medicine 2008 47 7 569 575 2-s2.0-44849126116 10.2169/internalmedicine. 47.0595
30. Shin W. G., Park S. H., Jang M. K., Hahn T. H., Kim J. B., Lee M. S., Kim D. J., Jun S.-Y., Park C. K., Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Digestive and Liver Disease 2008 40 4 267 274 2-s2.0-39749134902 10.1016/j.dld.2007.10.011
31. Wang H., Xue L., Yan R., Zhou Y., Wang M. S., Cheng M. J., Huang H. J., Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT. Journal of Viral Hepatitis 2013 20 4 e3 e10
32. Liu H.-B., Zhou J.-P., Zhang Y., Lv X.-H., Wang W., Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis B. Clinica Chimica Acta 2011 412 1-2 33 37 2-s2.0-78650515011 10.1016/j.cca.2010.08.032
33. Ucar F., Sezer S., Ginis Z., Ozturk G., Albayrak A., Basar O., Ekiz F., Coban S., Yuksel O., Armutcu F., APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B. European Journal of Gastroenterology & Hepatology 2013 25 9 1076 1081
34. Haydon G. H., Jalan R., Ala-Korpela M., Hiltunen Y., Hanley J., Jarvis L. M., Ludlum C. A., Hayes P. C., Prediction of cirrhosis in patients with chronic hepatitis C infection by artificial neural network analysis of virus and clinical factors. Journal of Viral Hepatitis 1998 5 4 255 264 2-s2.0-0031871764 10.1046/j.1365-2893.1998.00108.x
35. Cazzaniga M., Salerno F., Borroni G., Ceriani R., Stucchi G., Guerzoni P., Casiraghi M. A., Tommasini M., Prediction of asymptomatic cirrhosis in chronic hepatitis C patients: accuracy of artificial neural networks compared with logistic regression models. European Journal of Gastroenterology and Hepatology 2009 21 6 681 687 2-s2.0-67649635437 10.1097/MEG.0b013e328317f4da
36. Wang D., Wang Q., Shan F., Liu B., Lu C., Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers. BMC Infectious Diseases 2010 10, article 251 2-s2.0-77955827144 10.1186/1471-2334-10-251
37. Hsieh Y.-Y., Tung S.-Y., Lee I.-L., Lee K., Shen C.-H., Wei K.-L., Chang T.-S., Chuang C.-S., Wu C.-S., Lin Y.-H., FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis. Chang Gung Medical Journal 2009 32 6 614 622 2-s2.0-74949115003
38. Hu Z., Sun Y., Wang Q., Han Z., Huang Y., Liu X., Ding C., Hu C., Qin Q., Deng: A., Red blood cell distribution width is a potential prognostic index for liver disease. Clinical Chemistry and Laboratory Medicine 2013 51 7 1403 1408
39. Lou Y., Wang M., Mao W., Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS One 2012 7 5 e37644
40. Milić S., Mikolašević I., Radić M., Hauser G., Štimac D., Clinical utility of red cell distribution width in alcoholic and non-alcoholic liver cirrhosis. Collegium Antropologicum 2011 35 2 335 338 2-s2.0-80054095597
41. Lippi G., Targher G., Montagnana M., Salvagno G. L., Zoppini G., Guidi G. C., Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Archives of Pathology and Laboratory Medicine 2009 133 4 628 632
42. Mackelaite L., Alsauskas Z. C., Ranganna K., Renal failure in patients with cirrhosis. The Medical Clinics of North America 2009 93 4 855 869 2-s2.0-67649408821 10.1016/j.mcna.2009.03.003
43. Lippi G., Targher G., Montagnana M., Salvagno G. L., Zoppini G., Guidi G. C., Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients. Scandinavian Journal of Clinical and Laboratory Investigation 2008 68 8 745 748 2-s2.0-57349151070 10.1080/00365510802213550
44. Forns X., Ampurdanès S., Llovet J. M., Aponte J., Quintó L., Martínez-Bauer E., Bruguera M., Sánchez-Tapias J. M., Rodés J., Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002 36 4, part 1 986 992 2-s2.0-0036789328 10.1016/S0270-9139(02)00107-6
45. Fung J., Lai C.-L., Fong D. Y.-T., Yuen J. C.-H., Wong D. K.-H., Yuen M.-F., Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Liver International 2008 28 10 1408 1416 2-s2.0-54049140378 10.1111/j.1478-3231.2008. 01784.x
46. Ma J., Jiang Y., Gong G., Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection. European Journal of Gastroenterology & Hepatology 2013 25 4 428 434